Answers are grounded in this paper and cite their sources.
experiments showed that the MNMCF-guided CDT/PDT combination therapy could effectively ablate tumors without the drawbacks of poor tolerability and potential long-term side effects. Therefore, the prepared MNMCF NPs can be used as promising candidates for synergistic CDT/PDT tumor therapy.
No takes yet. Share an insight, caveat, or question.
Mo et al. (2022) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: